Cargando…

In Vitro and In Vivo Preclinical Testing of Pericyte‐Engineered Grafts for the Correction of Congenital Heart Defects

BACKGROUND: We have previously reported the possibility of using pericytes from leftovers of palliative surgery of congenital heart disease to engineer clinically certified prosthetic grafts. METHODS AND RESULTS: Here, we assessed the feasibility of using prosthetic conduits engineered with neonatal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alvino, Valeria Vincenza, Kilcooley, Michael, Thomas, Anita C., Carrabba, Michele, Fagnano, Marco, Cathery, William, Avolio, Elisa, Iacobazzi, Dominga, Ghorbel, Mohamed, Caputo, Massimo, Madeddu, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070228/ https://www.ncbi.nlm.nih.gov/pubmed/32067581 http://dx.doi.org/10.1161/JAHA.119.014214

Ejemplares similares

Reconstruction of the Swine Pulmonary Artery Using a Graft Engineered With Syngeneic Cardiac Pericytes
por: Alvino, Valeria Vincenza, et al.
Publicado: (2021)

Accelerated Cardiac Aging in Patients With Congenital Heart Disease
por: Iacobazzi, Dominga, et al.
Publicado: (2022)

Corrigendum: Accelerated cardiac aging in patients with congenital heart disease
por: Iacobazzi, Dominga, et al.
Publicado: (2022)

Umbilical Cord Pericytes Provide a Viable Alternative to Mesenchymal Stem Cells for Neonatal Vascular Engineering
por: Cathery, William, et al.
Publicado: (2021)

Cardiac pericyte reprogramming by MEK inhibition promotes arteriologenesis and angiogenesis of the ischemic heart
por: Avolio, Elisa, et al.
Publicado: (2022)

Graft rejection in paediatric congenital heart disease
por: Harris, Amy G., et al.
Publicado: (2023)

Successful Reconstruction of the Right Ventricular Outflow Tract by Implantation of Thymus Stem Cell Engineered Graft in Growing Swine
por: Albertario, Ambra, et al.
Publicado: (2019)

Approaches for the isolation and long-term expansion of pericytes from human and animal tissues
por: Alvino, Valeria Vincenza, et al.
Publicado: (2023)

Concise Review: The Regenerative Journey of Pericytes Toward Clinical Translation
por: Cathery, William, et al.
Publicado: (2018)

Wharton’s Jelly–Mesenchymal Stem Cell–Engineered Conduit for Pulmonary Artery Reconstruction in Growing Piglets
por: Rapetto, Filippo, et al.
Publicado: (2022)

Expansion and Characterization of Neonatal Cardiac Pericytes Provides a Novel Cellular Option for Tissue Engineering in Congenital Heart Disease
por: Avolio, Elisa, et al.
Publicado: (2015)

Reconstruction of the pulmonary artery by a novel biodegradable conduit engineered with perinatal stem cell-derived vascular smooth muscle cells enables physiological vascular growth in a large animal model of congenital heart disease
por: Ghorbel, Mohamed T., et al.
Publicado: (2019)

COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention
por: Iacobazzi, Dominga, et al.
Publicado: (2020)

Personalized Cardiovascular Regenerative Medicine: Targeting the Extreme Stages of Life
por: Madeddu, Paolo, et al.
Publicado: (2019)

The adipokine leptin modulates adventitial pericyte functions by autocrine and paracrine signalling
por: Riu, Federica, et al.
Publicado: (2017)

Perivascular cells and tissue engineering: Current applications and untapped potential
por: Avolio, Elisa, et al.
Publicado: (2017)

Fabrication of New Hybrid Scaffolds for in vivo Perivascular Application to Treat Limb Ischemia
por: Carrabba, Michele, et al.
Publicado: (2020)

Murine studies and expressional analyses of human cardiac pericytes reveal novel trajectories of SARS-CoV-2 Spike protein-induced microvascular damage
por: Avolio, Elisa, et al.
Publicado: (2023)

Stem cell therapy and tissue engineering for correction of congenital heart disease
por: Avolio, Elisa, et al.
Publicado: (2015)

Dimethyl-2-oxoglutarate improves redox balance and mitochondrial function in muscle pericytes of individuals with diabetes mellitus
por: Faulkner, Ashton, et al.
Publicado: (2020)

Cellular and molecular basis of RV hypertrophy in congenital heart disease
por: Iacobazzi, D, et al.
Publicado: (2016)

Biological Scaffolds for Congenital Heart Disease
por: Harris, Amy G., et al.
Publicado: (2023)

Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease
por: Bond, Andrew R, et al.
Publicado: (2018)

Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts
por: Carrabba, Michele, et al.
Publicado: (2018)

Transplantation of Allogeneic Pericytes Improves Myocardial Vascularization and Reduces Interstitial Fibrosis in a Swine Model of Reperfused Acute Myocardial Infarction
por: Alvino, Valeria Vincenza, et al.
Publicado: (2018)

Angiogenesis in Tissue Engineering: As Nature Intended?
por: Mastrullo, Valeria, et al.
Publicado: (2020)

BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and mice
por: Cattaneo, Monica, et al.
Publicado: (2023)

MicroRNA-532-5p Regulates Pericyte Function by Targeting the Transcription Regulator BACH1 and Angiopoietin-1
por: Slater, Sadie C., et al.
Publicado: (2018)

The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease
por: Avolio, Elisa, et al.
Publicado: (2021)

The bone marrow pericyte: an orchestrator of vascular niche
por: Mangialardi, Giuseppe, et al.
Publicado: (2016)

Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch Operation
por: Rapetto, Filippo, et al.
Publicado: (2021)

The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice
por: Gu, Yue, et al.
Publicado: (2023)

Chronic hypoxia down‐regulates tight junction protein ZO‐2 expression in children with cyanotic congenital heart defect
por: Jenkins, Emma L., et al.
Publicado: (2015)

Gab1 Is Modulated by Chronic Hypoxia in Children with Cyanotic Congenital Heart Defect and Its Overexpression Reduces Apoptosis in Rat Neonatal Cardiomyocytes
por: Cherif, Myriam, et al.
Publicado: (2015)

EBF1 is expressed in pericytes and contributes to pericyte cell commitment
por: Pagani, Francesca, et al.
Publicado: (2021)

Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery()
por: Ellison-Hughes, Georgina M., et al.
Publicado: (2017)

New Insights into NF-κB Signaling in Innate Immunity: Focus on Immunometabolic Crosstalks
por: Iacobazzi, Dominga, et al.
Publicado: (2023)

Activation of Bone Marrow Adaptive Immunity in Type 2 Diabetes: Rescue by Co-stimulation Modulator Abatacept
por: Santopaolo, Marianna, et al.
Publicado: (2021)

Cell Sources for Tissue Engineering Strategies to Treat Calcific Valve Disease
por: Jover, Eva, et al.
Publicado: (2018)

Bicuspid Aortic Valve Alters Aortic Protein Expression Profile in Neonatal Coarctation Patients
por: Skeffington, Katie L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6h73puuqk35gn1o1lcedgb7rmj